Divi's Laboratories Ltd. Financials: Check Share Price, Balance Sheet, Annual Report and Quarterly Results for Company Analysis

Divi's Laboratories Ltd. is at the forefront of India's pharmaceutical industry, renowned for its specialization in manufacturing active pharmaceutical ingredients (API) and intermediates. This article aims to offer a detailed analysis of Divi's Laboratories Ltd.'s stock through the lens of a long-term investor. We will scrutinize several critical facets, including the share price, balance sheet, annual report, dividends, quarterly performance, stock price trends, price charts, latest news, conference calls (concalls), transcripts, investor briefings, details about the company's promoters, and the shareholder structure.

Divi's Laboratories Ltd. Share Price:

Divi's Laboratories Ltd. occupies a key position in India's pharmaceutical sector, which is distinguished by its expertise in producing active pharmaceutical ingredients (API) and intermediates. This article is designed to present an exhaustive review of Divi's Laboratories Ltd.'s stock from the perspective of a long-term investor. Critical aspects such as the share price, financial health (balance sheet), comprehensive annual reports, dividend payouts, quarterly results, trends in stock prices, analytical charts, recent news, earnings calls (concalls), transcripts, investor presentations, information on the company's promoters, and the composition of its shareholder base will be thoroughly explored.

Divi's Laboratories Ltd. Balance Sheet:

Divi's Laboratories Ltd.'s balance sheet provides crucial information about its financial health. The company's assets include fixed assets, investments, and inventory, while liabilities include borrowings and other liabilities. Equity includes share capital, reserves, and surplus. Long-term investors can use our pre-built screening tools to analyze Divi's Laboratories Ltd.'s balance sheet and identify any red flags. The company's balance sheet has been strong over the past few years, reflecting the company's ability to generate cash and manage its liabilities.

Divi’s Laboratories Reserves Trend

The highlighted company’s reserves have also revealed a progressive upward trend within the last five years which supports the retained earnings and the company’s financial position. Total reserves which were Rs 7,263.60 crores of the company as on 31st march 2020 reached Rs 13,431 crores as of 31st march 2024. This growth pattern shows that the company engages in profit making and reinvestment into the business.

Company’s debt position

Following the adjusted section, the specifics of the current liabilities and the company’s borrowings can also be seen in the absence of debt liabilities from the year 2020 to 2024. Lack of debt has made its financial position strong; this cuts out the likelihood of default on interest and gives room for future expansion.

The Asset Base of Divi’s Laboratories

The data also show that there was expansion in the asset base of Divi’s Laboratories during the year in question as the company’s total assets increased from Rs 9,407.81 crores in March 2020 to Rs 15,833 crores in March 2024. Going down to the net block, it has raised from Rs 2,776.26 crores to Rs 4,737 crores taking place in the other fixed assets depicting consistent capital expenditures. In the same order, capital work-in-progress (WIP) was also volatile in the financial year under consideration; it declined to Rs 778 crores by March 2023 and increased again to Rs 778 crores by March 2024.

Current liabilities and assets of Divi’s Laboratories

The current liabilities changed and fell to Rs 1,511 crores in March 2023 and then rose to Rs 1,730 crores in March 2024. But one cannot argue that current assets have only increased and become better from Rs 3,200 crore in March 2016 to Rs 10,043 crore in March 2024.

The above data is the summarized and analyzed Balance Sheet for Division Laboratories for the independent view. Accordingly, for investors, it will be useful to track sectors with low-debt companies to explore more stable investment prospects.

Divi's Laboratories Ltd. Annual Report:

Divi's Laboratories Ltd. releases an annual report that provides detailed information about the company's financial performance, strategic initiatives, and future plans. The annual report includes a letter from the Chairman, financial statements, and management discussion and analysis. Long-term investors can download Divi's Laboratories Ltd.'s annual report from Ticker and use it to make informed investment decisions. The annual report provides valuable insights into the company's operations and financial performance.

Divi's Laboratories Ltd. Dividend:

Divi's Laboratories Ltd. pays dividends to its shareholders. The company has a consistent dividend policy and pays dividends regularly. Long-term investors should consider this when evaluating Divi's Laboratories Ltd.'s stock. Our pre-built screening tools can be used to analyze the company's dividend history and identify any trends or patterns.

Divi's Laboratories Ltd. Quarterly Results:

Divi's Laboratories Ltd. releases its quarterly results every three months. These provide information about the company's revenue, earnings, and expenses. Long-term investors can use our pre-built screening tools to analyze Divi's Laboratories Ltd.'s quarterly results and identify any trends or patterns. The quarterly results are an important indicator of the company's financial health and performance.

Divi's Laboratories Ltd. Stock Price:

The stock price of Divi's Laboratories Ltd. is affected by various factors, such as the company's financial performance, global economic conditions, and market sentiment. Long-term investors can use our pre-built screening tools to track Divi's Laboratories Ltd.'s stock price and identify potential buying opportunities. The stock price of Divi's Laboratories Ltd. has shown a consistent upward trend over the past few years, reflecting the company's strong brand, product portfolio, and customer focus.

Divi's Laboratories Ltd. Price Chart:

A price chart provides a visual representation of a company's stock price over a period of time. Long-term investors can use our pre-built screening tools to analyze Divi's Laboratories Ltd.'s price chart and identify any trends or patterns. The price chart shows that the stock price of Divi's Laboratories Ltd. has shown a consistent upward trend over the past few years, reflecting the company's strong brand, product portfolio, and customer focus.

Divi's Laboratories Ltd. News:

Keeping up to date with the latest news about Divi's Laboratories Ltd. is important for investors. Our website provides the latest news about Divi's Laboratories Ltd. from various sources, such as financial news websites and social media. Long-term investors can use this information to make informed investment decisions.

Divi's Laboratories Ltd. Concall:

Divi's Laboratories Ltd. holds conference calls with analysts and investors to discuss its financial performance and future plans. Long-term investors can listen to Divi's Laboratories Ltd.'s concall and use the information provided to make informed investment decisions. Our website provides information about upcoming concalls and links to listen to past concalls.

Divi's Laboratories Ltd. Transcripts:

Transcripts of Divi's Laboratories Ltd.'s concalls are available on our website. Long-term investors can download the transcripts and use them to analyze the company's financial performance and future plans. The transcripts provide valuable insights into the company's operations and financial performance.

Divi's Laboratories Ltd. Investor Presentations:

Divi's Laboratories Ltd. provides investor presentations on its website. These presentations provide information about the company's financial performance, strategic initiatives, and future plans. Long-term investors can download Divi's Laboratories Ltd.'s investor presentations from our website and use them to make informed investment decisions. The investor presentations provide valuable insights into the company's operations and financial performance.

Divi's Laboratories Ltd. Promoters:

Promoters are individuals or entities that have a significant stake in a company. Divi's Laboratories Ltd.'s promoters include Dr Murali K Divi, Dr Divi Murali Krishna, and related entities. Long-term investors can use our pre-built screening tools to analyze Divi's Laboratories Ltd.'s promoter holdings and identify any potential conflicts of interest. The promoter holdings of Divi's Laboratories Ltd. are relatively stable, which is a positive sign for long-term investors.

Divi's Laboratories Ltd. Shareholders:

Divi's Laboratories Ltd. has a large number of shareholders, including institutional and individual investors. Long-term investors can use our pre-built screening tools to analyze Divi's Laboratories Ltd.'s shareholder base and identify any potential risks or opportunities. Divi's Laboratories Ltd.'s shareholder base is diverse, which is a positive sign for long-term investors.

Divi's Laboratories Ltd. Premium Features:

Our website provides premium features tools such as DCF Analysis, BVPS Analysis, Earnings multiple approaches, and DuPont analysis. These tools can help long-term investors make better investment decisions by providing more detailed insights into the company's financial performance and valuation.

Divi's Laboratories Limited ROCE

The Return on Capital Employed (ROCE) is a crucial measure of a company's profitability and efficiency in utilizing its capital. As an investor or analyst, it is essential to evaluate this metric to assess the financial performance of Divi’s Laboratories Limited. By analyzing the ROCE, you can gain insights into how effectively the company generates profits from its capital investments. All the data related to ROCE can be found in the financials table or ratio section on this page.

Divi's Laboratories Limited EBITDA

EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is a vital measure of a company's operating performance. It allows investors to evaluate Divi’s Laboratories Limited's profitability before the impact of non-operating factors such as interest expenses and taxes. By analyzing the EBITDA, you can understand the company's ability to generate earnings from its core operations. For detailed information on Divi’s Laboratories Limited's EBITDA, refer to the financials table or ratio section above.

Divi's Laboratories Limited DPS

Dividend Per Share (DPS) is an important metric for investors seeking regular income through dividend payments. By assessing Divi’s Laboratories Limited's DPS, you can gauge the company's commitment to distributing profits to its shareholders. DPS signifies the amount of dividend each share receives, providing insights into the company's financial health and profitability. The DPS data for Divi’s Laboratories Limited can be found in the financials table or ratio section on this page.

Divi's Laboratories Limited EPS

Earnings Per Share (EPS) is a key indicator of a company's profitability, reflecting the portion of the earnings allocated to each outstanding share of Divi’s Laboratories Limited. By analyzing the EPS, investors can assess the company's ability to generate profits and its potential for growth. A higher EPS suggests a company's ability to generate greater earnings for its shareholders. You can find the EPS data for Divi’s Laboratories Limited in the financials table or ratio section available on this page.